A Tyra Bioscience insider purchased $2.5M in shares, while a Broadcom insider sold $1.5M in company shares Welcome to "Fly Insider," The Fly's weekly recap of notable insider stock transactions.
NOTABLE INSIDER PURCHASES: Significant insider purchases reported in the prior week from September 13 through September 17 include:
- Director of Tyra Biosciences (TYRA) Robert More purchased 156,250 shares of company stock at $16 per share for a total transaction value of $2,500,000
- Chairman of Continental Resources (CLR) Harold Hamm purchased purchased 261,709 shares of company stock at $41.99 per share for a total transaction value of $10,988,114
- CEO of Oscar Health (OSCR) Mario Schlosser purchased 57,300 shares of company stock at $17.53 per share for a total transaction value of $1,004,515
- Director of Gannett (GCI) Laurence Tarica purchased 26,000 shares of company stock at $6.42 per share for a total transaction value of $166,920
NOTABLE INSIDER SALES: Significant insider sales reported in the prior week from September 13 through September 17 include:
- Officer of Airbnb (ABNB) Joseph Gebbia sold 204,166 shares of company stock at $164.57 per share for a total transaction amount of $33,600,170
- Officer of Akero Therapeutics (AKRO) sold 12,500 shares of company stock at $24.69 per share for a total transaction value of $308,605
- Chairman of Bill.Com (BILL) Rene Lacerte sold 10,000 shares of company stock at $288.28 per share for a total transaction value of $2,882,765
- COO of Broadcom (AVGO) Charlie Kawass sold 3,000 shares of company stock at $500.83 per share for a total transaction value of $1,502,491
NOTABLE PRICE MOVEMENT AFTER INSIDER TRANSACTION: Shares of Tyra Biosciences are up over 20% since insider director Robert More purchased 156,250 shares of company stock at $16 per share, while shares of Broadcom are down 4% since insider COO Charlie Kawas sold 3,000 shares of company stock at $500.83 per share.
Symbols:
TYRA CLR OSCR GCI ABNB - $159.54 /
-7.435 (-4.45%)
AKRO Keywords: insider trading, insider buying, insider selling, executive trading, executive buying, executive selling, stock transactions, SEC